Details for Patent: 5,854,259
✉ Email this page to a colleague
Summary for Patent: 5,854,259
Title: | Quinoline type mevalonolactones |
Abstract: | Described herein are mevalonolactone derivatives having a quinoline ring of formula (I) ##STR1## wherein the R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Y and Z variables are described therein. |
Inventor(s): | Fujikawa; Yoshihiro (Funabashi, JP), Suzuki; Mikio (Funabashi, JP), Iwasaki; Hiroshi (Funabashi, JP), Sakashita; Mitsuaki (Saitama-ken, JP), Kitahara; Masaki (Saitama-ken, JP) |
Assignee: | Nissan Chemical Industries Ltd. (Tokyo, JP) |
Application Number: | 07/978,884 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 5,854,259
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,854,259
International Family Members for US Patent 5,854,259
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 114645 | ⤷ Sign Up | |||
Canada | 1336714 | ⤷ Sign Up | |||
Germany | 3852243 | ⤷ Sign Up | |||
European Patent Office | 0304063 | ⤷ Sign Up | |||
Spain | 2067460 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |